Tradewinds Capital Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05K Hold
100
﹤0.01% 564
2026
Q1
$1.59K Hold
100
﹤0.01% 583
2025
Q4
$2.63K Hold
100
﹤0.01% 510
2025
Q3
$2.26K Hold
100
﹤0.01% 506
2025
Q2
$1.99K Hold
100
﹤0.01% 476
2025
Q1
$1.69K Hold
100
﹤0.01% 499
2024
Q4
$1.85K Hold
100
﹤0.01% 499
2024
Q3
$2.17K Hold
100
﹤0.01% 466
2024
Q2
$1.96K Hold
100
﹤0.01% 446
2024
Q1
$2.17K Sell
100
-100
-50% -$2.48K ﹤0.01% 412
2023
Q4
$5.78K Buy
200
+150
+300% +$4.01K ﹤0.01% 278
2023
Q3
$1.34K Hold
50
﹤0.01% 371
2023
Q2
$1.85K Hold
50
﹤0.01% 335
2023
Q1
$1.56K Sell
50
-50
-50% -$1.61K ﹤0.01% 352
2022
Q4
$2.98K Buy
100
+50
+100% +$1.79K ﹤0.01% 331
2022
Q3
$2K Hold
50
﹤0.01% 327
2022
Q2
$3K Hold
50
﹤0.01% 314
2022
Q1
$3K Sell
50
-40
-44% -$2.63K ﹤0.01% 621
2021
Q4
$9K Buy
90
+40
+80% +$3.52K ﹤0.01% 503
2021
Q3
$4K Hold
50
﹤0.01% 583
2021
Q2
$5K Hold
50
﹤0.01% 565
2021
Q1
$5K Buy
+50
New +$5.16K ﹤0.01% 541

Other funds holding FLGT

Tradewinds Capital Management's FLGT Position: Q2 2026 in Review

Tradewinds Capital Management held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 100 shares worth $2.05K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Tradewinds Capital Management first reported a position in FLGT in Q1 2021 and has held it in 22 quarters since. The position peaked at $9K in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Tradewinds Capital Management held 100 shares of Fulgent Genetics worth $2.05K as of Q2 2026.
  • Tradewinds Capital Management left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #564 holding.
  • Tradewinds Capital Management first reported a position in Fulgent Genetics in Q1 2021 and has held it in 22 quarters since.
  • Tradewinds Capital Management's Fulgent Genetics position peaked at $9K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.